Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • ty23991
    Member
    • May 2015
    • 24

    #1

    Best practice for preprocessing the bam file for copy number estimation

    Hi all,

    There are known limitations involved in the copy number estimation from exome sequencing (Tumor/Normal).

    For instance the following paper provides some insights.
    Teo et al. Statistical challenges associated with detecting copy number variations with NGS. Bioinfo. 2012


    I have two questions:

    1. In case of T/N paired analysis, what is the best practice for data preprocessing ?
    Currently available duplicates removal approaches have limitations in discriminating true PCR duplicates and genuine biological sequences.

    What is the best approach for duplicates removal?
    What is the best suitable aligner for preparing the bam file for CNV estimation ?

    2. In case normal reference bam is unavailable, what are the best recommended tools for copy number analysis in case of exome sequencing ?


    Thanks
    Last edited by ty23991; 03-21-2016, 12:07 PM.
  • dmb107
    Junior Member
    • Oct 2014
    • 6

    #2
    Originally posted by ty23991 View Post
    Hi all,

    What is the best approach for duplicates removal?
    What is the best suitable aligner for preparing the bam file for CNV estimation ?

    Thanks
    I am also interested in best practices for preprocessing bam files in preparation for CNV estimation.

    In addition to these questions, should reads with low MAPQ be filtered out?

    Thanks, all.

    Comment

    • maxsalm
      Member
      • Feb 2015
      • 18

      #3
      Hi there,

      personally I have had success with BWA/BWA-MEM followed by Picard's MarkDuplicates. N.B. It is important to align to the FULL genome (not just canonical chromosomes).

      Comment

      Latest Articles

      Collapse

      • SEQadmin2
        Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
        by SEQadmin2



        Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

        Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
        ...
        10-14-2026, 09:55 AM
      • SEQadmin2
        New Genomics Technologies Take Aim at Long-Standing Limits
        by SEQadmin2


        Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.

        We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing
        ...
        09-28-2026, 10:25 AM

      ad_right_rmr

      Collapse

      News

      Collapse

      Topics Statistics Last Post
      Started by SEQadmin2, 10-22-2026, 11:13 AM
      0 responses
      26 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 10-22-2026, 10:48 AM
      0 responses
      20 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 10-15-2026, 10:52 AM
      0 responses
      36 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 10-14-2026, 05:39 AM
      0 responses
      43 views
      0 reactions
      Last Post SEQadmin2  
      Working...